Fredun Pharmaceuticals Ltd

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements)Regulations 2015 we hereby confirm that there is no deviation or variation in the use of proceeds from the objects stated in in the Explanatory Statement to the Notice of Extra-Ordinary General Meeting of the Company dated September 22 2021. A statement confirming that there is no deviation or variation in the utilisation of these proceeds for quarter ended December 31 2021 duly reviewed by the Audit Committee is attached.